Pemetrexed Pathway-Associated Germline Polymorphisms: A Useful Tool for Treatment Individualization?

W.A. Buikhuisen, J.A. Burgers, A.D. Vincent, J.H.M. Schellens, J.H. Beijnen, E.F. Smit, M. Joerger

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)E482-E483
JournalJournal of Clinical Oncology
Volume28
Issue number27
DOIs
Publication statusPublished - 2010

Cite this